This book investigates the evolving landscape of biosimilar and generic medications within the field of ophthalmology, focusing on their efficacy, safety, and integration into clinical practice. Authored by leading experts in the field, it synthesizes current research, clinical trial data, and regulatory considerations to provide a comprehensive overview. The work aims to equip ophthalmologists with the knowledge necessary to make informed decisions regarding these increasingly important therapeutic options for their patients.

This text is positioned as a crucial resource for ophthalmologists and other eye care professionals navigating the complexities of biosimilar and generic medications. Its focus on evidence-based practice and clinical application suggests it is intended for practitioners seeking to understand and implement these cost-effective alternatives. The comprehensive scope, covering regulatory, clinical, and economic aspects, indicates a thorough approach to the subject matter.